{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:33:42Z","timestamp":1789054422814,"version":"build-2803163510"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":3544,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:p>This paper focuses on the importance of data collected not only from controlled clinical trials, but also from naturalistic treatment experience. In particular we examine the use of divalproex sodium either as monotherapy or as part of combined therapy on an in\u2010patient ward for adolescents aged 13\u201318 years. All admissions in which divalproex sodium use was attempted (<jats:italic>n<\/jats:italic>=36) were analysed over a 1\u2010year period. The most common use was in patients with a mixed\u2010presentation bipolar disorder (<jats:italic>n<\/jats:italic>=16), followed by patients with major depression (<jats:italic>n<\/jats:italic>=7), mania (<jats:italic>n<\/jats:italic>=4) or psychoses not otherwise specified (<jats:italic>n<\/jats:italic>=4). Divalproex sodium use was evaluated in the control of mania, psychosis, agitation, mood swings, aggression and\/or anxiety. Overall, the use of divalproex sodium was associated with a marked improvement along all psychopathological variables in the vast majority of patients. Few side\u2010effects or medical complications were noted. We believe that divalproex sodium is a potentially useful drug in adolescent patients with varying forms of psychopathology.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1998.tb09994.x","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T17:36:16Z","timestamp":1194975376000},"page":"236-240","source":"Crossref","is-referenced-by-count":38,"title":["Naturalistic experience with the use of divalproex sodium on an in\u2010patient unit for adolescent psychiatric patients"],"prefix":"10.1111","volume":"97","author":[{"given":"J. A.","family":"Deltito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Damore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zambenedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,11,13]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"279","article-title":"Psychiatric classification reconceptualized for anxiety and depression research","volume":"3","author":"Deltito JA","year":"1989","journal-title":"J Clin Res Drug Dev"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1985.tb03413.x"},{"key":"e_1_2_1_4_2","first-page":"446","volume-title":"The pharmacological basis of therapeutics","author":"Rall TW","year":"1985"},{"key":"e_1_2_1_5_2","first-page":"300","article-title":"The effect of valproate on bipolar spectrum temperamental disorders","volume":"54","author":"Deltito JA","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_6_2","first-page":"213","article-title":"Divalproex sodium treatment in late adolescent and young adult acute mania","volume":"29","author":"Papatheodorou G","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(80)90029-2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-4993(18)30608-4"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00048678709160897"},{"key":"e_1_2_1_10_2","first-page":"596","article-title":"Mania in adolescence","volume":"47","author":"Hsu LKG","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198705000-00019"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(88)90023-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770260094012"},{"key":"e_1_2_1_14_2","unstructured":"KutcherS BoulosC.Schizophrenia and mania in adolescents: presentation and treatment issues. Paper presented at Current Topics in Adolescent Psychiatry University of Toronto Update Series Toronto Ontario Canada November 1990."},{"key":"e_1_2_1_15_2","first-page":"44","article-title":"Valproate in anxiety and withdrawal symptoms","volume":"50","author":"Roy\u2010Byrne PR","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_16_2","first-page":"430","article-title":"Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes","volume":"56","author":"Horne M","year":"1995","journal-title":"J Clin Pyschiatry"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401239409148834"},{"key":"e_1_2_1_18_2","first-page":"11","article-title":"Valproate pretreatment for the difficult\u2010to\u2010treat patient with OCD (letter to the editor)","volume":"55","author":"Deltito JA","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_19_2","volume-title":"Depression in young adults","author":"Deltito JA","year":"1996"},{"key":"e_1_2_1_20_2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.1.108"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex versus lithium and placebo in the treatment of mania","volume":"271","author":"Bowden CL","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199504000-00006"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_1_25_2","first-page":"16","article-title":"Sodium valproate: its use in primary psychiatric disorders","volume":"7","author":"McElroy SL","year":"1987","journal-title":"J Clin Psychopharmacology"},{"key":"e_1_2_1_26_2","first-page":"25","volume-title":"Use of anticonvulsants in psychiatry: recent advances","author":"McElroy SL","year":"1988"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1998.tb09994.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1998.tb09994.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T11:37:39Z","timestamp":1698493059000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1998.tb09994.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1111\/j.1600-0447.1998.tb09994.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1998.tb09994.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}